Cancer-specific distress is related to women's decisions to undergo BRCA1 testing

Cancer Research Therapy and Control

Volumn 8, Issue 1-2, 1999, Pages 61-68

  Valdimarsdottir, Heiddis B ^a   Bovbjerg, Dana H ^a   Brown, Karen ^a   Jacobsen, Paul ^a   Schwartz, Marc D ^a   Bleiker, Eveline ^a   Offit, Kenneth ^a   Borgen, Patrick ^a   Heerdt, Alexandra ^a   Van Zee, Kimberly ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

BRCA1; Decision making; Distress; Genetic testing

Indexed keywords

ADULT; AGED; BREAST CANCER; CANCER RISK; CONFERENCE PAPER; DECISION MAKING; DEMOGRAPHY; DISTRESS SYNDROME; FAMILY HISTORY; FEMALE; GENETIC COUNSELING; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 0032906098     PISSN: 10640525     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Birch JM. Familial cancer syndromes and clusters. British Medical Bulletin 1994: 50:624-639.
2. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCAI and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995; 57:1457-1462.
3. Ford D, Easton DF. The genetics of breast and ovarian cancer. British Journal of Cancer 1995; 72:805-812.
4. Eby N, Chang-Claude J. Bishop DT. Familial risk and genetic susceptibility for breast cancer. Cancer Causes and Control 1994:5:458-470.
5. Struewing JP. Hartge P, Wacholder S, Baker SM. Berlin M, Me Adams M. et al. The risk of cancer associated with specific mutations of BRCA I and BRCA2 among Ashkenazi Jews. N Engl J Med 1997: 336:1401-1408.
6. Whittemore AS, Gong G, Itnyre J. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancerresults from three U.S. population-based case-control studies of ovarian cancer. American Journal of Human Genetics 1997; 60:496-504.
7. Schräg D, Kuntz KM, Garber JE, Weeks JC. Decision analysis - Effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 1997; 336:1465-1471.
8. [8| Baum A, Friedman AL. Zakowski SG. Stress and genetic testing for disease risk. Health Psychology 1997; 16:8-19.
9. Burke W, Daly M, Garber J, Botkin J, Kahn M, Lynch P. et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. JAMA 1997; 277:997-1003.
10. Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, et al. Assessment and counseling for women with a family history of breast cancer. JAMA 1995; 273:577-585.
11. Lerman C, Croyle R. Emotional and behavioral responses to genetic testing for suceptibility to cancer. Oncology 1996; 10:191-195.
12. Lerman C, Daly M, Masny A, Balshem AM. Attitudes about genetic testing for breast-ovarian cancer susceptibility. Journal of Clinical Oncology 1994; 12 :843-850.
13. Struewing J, Lerman C, Kase R, Giambarresi T, Tucker M. Anticipated uptake and impact of genetic testing for inherited breast and ovarian cancer. .Cancer Epidemiology, Biomark ers and Prevention 1995; 4:169-173.
14. Croyle RT, Lerman C. Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. Prevent Med 1993; 22:284-292.
15. Craufurd D, Dodge A, Kerzin-Storrar L, Harris R. Uptake of presymtomatic predictive testing for Huntington's disease. Lancet 1989; 22:284-292.
16. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, BonneyG, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. JAMA 1996; 275:18851892.
17. Lerman C, Schwartz MD, Narod S, Lynch HT. The influence of psychological distress on use of genetic testing for cancer risk. Journal of Consulting and Clinical Psychology 1997; 65:414-420.
18. Kash KM, Holland JC, Halper MS, Miller DG. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992; 84:24-30.
19. Lerman C, Kash K, Stefanek M. Younger women at increased risk for breast cancer: Perceived risk, psychological well-being, and surveillance behavior. Monogr Natl Cancer Inst 1994; 16:171-176.
20. Lerman C, Daly M, Sands C, Balshem AM, Lustbader E, Heggan T, et al. Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 1993; 85:1074-1080.
21. [21 ] Stefanek ME, Wilcox P. First degree relatives of breast cancer patients: Screening practices and provision of risk information. Cancer Detection and Prevention 1991; 15:379-384.
22. McCaul KD, Schroeder DM, Reid PA. Breast cancer worry and screening: Some prospective data. Health Psychology 1996; 15:430-433.
23. Hailey BJ. Family history of breast cancer and screening behavior: An inverted U-shaped curve? Medical Hypotheses 1991; 36:397-403.
24. Valdimarsdottir HB, Bovbjerg DH, Kash KM, Holland JC, Osborne MP, Miller DG. Psychological distress in women with a familial risk of breast cancer. Psycho-Oncology 1995; 4:133-141.
25. Zakowski SG, Valdimarsdottir H, Bovbjerg D, Borgen P, Holland J, Kash K, et al. Predictors of intrusive thoughts and avoidance in women with family histories of breast cancer. Annals of Behavioral Medicine 1998; In press.
26. Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C, et al. Effects of individualized breast cancer risk counseling: A randomized trial.. J Natl Cancer Inst 1995; 87:286-292.
27. Horowitz M, Wilner N, Alvarez W. Impact of event scale: A measure of subjective stress. Psychosomatic Medicine 1979; 41:209-218.